Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Fortis Healthcare...

    Fortis Healthcare seeks 15-day extension to declare Q2, Q3 results

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-02-14T19:11:13+05:30  |  Updated On 14 Feb 2018 7:11 PM IST
    Fortis Healthcare seeks 15-day extension to declare Q2, Q3 results

    Fortis Healthcare, India's second-largest hospital chain, has sought a 15-day extension to declare earnings for the second and third quarter of the current financial year citing statutory auditors' inability to complete the audit before the stipulated board meeting.


    The board of Fortis Healthcare was to consider financial results for July-September and October-December 2017 quarters at its meeting today.In a regulatory filing, the company said the meeting of the board of directors for today will go as scheduled and would consider the resignation of promoters, Malvinder Mohan Singh and Shivinder Mohan Singh from the board.Bloomberg had last week reported that Fortis could not declare the second quarter earnings within the stipulated 45- day period as its auditor, Deloitte Haskins & Sells LLP, refused to sign off on the results until about Rs 500 crore that Singh brothers took out from the company without board approval is accounted for or returned.Called for an explanation by stock exchanges, Fortis had on February 9 stated: "Fortis Hospitals Ltd, a wholly-owned subsidiary of Fortis Healthcare Ltd, has deployed funds in secured short-term investments with companies in the normal course of treasury operations."These entities have become part of the promoter group due to a shareholding change in those entities.


    Subsequently, the same loans have been recognised as related party transactions."The loans amounting to Rs 473 crore are adequately secured and repayment has since commenced, it added.In the regulatory filing today, Fortis said it has paid a fine of Rs 65.98 lakh to stock exchanges for "non-submission of un-audited financial results for the quarter ended September 30, 2017.


    "Media reports, it said, had enhanced "the scope of limited review audit by the statutory auditors for the quarters ended September 30, 2017, and December 31, 2017, which we also acknowledge and consider just and equitable in the interest of governance and investors at large."While the normal audit process was going on smoothly, after the aforesaid news items, our interaction with auditors indicates that the audit process may not complete before the stipulated date of the board meeting," it said.The board at its meeting today would discuss at length the resignation of executive chairman Malvinder Mohan Singh and vice chairman Shivinder Mohan Singh.


    "The said resignations will reduce the strength of the board from 7 to 5 and a discussion on this will also happen at the aforesaid meeting. This has created an impact on the overall process of completion of the audit process," the filing said.Fortis sought an extension for approving the financial results of the two quarters till February 28.The Singh brothers are also facing a lawsuit brought by New York-based private equity firm Siguler Guff & Co, which accused them of "syphoning" money out of another publicly- traded firm they control to help them manage their personal debts, according to Bloomberg.

    BloombergDeloitte HaskinsFortisFortis HealthcareHealthcareLLPMalvinder Mohan SinghShivinder Mohan SinghSiguler Guff & Costatutory auditorsstipulatedsyphoning
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok